Home
About
Overview
Sharing Data
ORCID
Help
History (41)
Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study).
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.
Proteolysis and class I major histocompatibility complex antigen presentation.
Exercise and energy intake in overweight, sedentary individuals.
Innate immune recognition of Yersinia pseudotuberculosis type III secretion.
See All 41 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Innate immune recognition of Yersinia pseudotuberculosis type III secretion.
Auerbuch V, Golenbock DT, Isberg RR. Innate immune recognition of Yersinia pseudotuberculosis type III secretion. PLoS Pathog. 2009 Dec; 5(12):e1000686.
View in:
PubMed
subject areas
Animals
Bacterial Proteins
Cell Line, Tumor
Cytokines
Gene Expression
Humans
Immunity, Innate
Kinetics
Macrophages
Mice
Nod1 Signaling Adaptor Protein
Nod2 Signaling Adaptor Protein
Secretory Pathway
Yersinia pseudotuberculosis
Yersinia pseudotuberculosis Infections
authors with profiles
Douglas T Golenbock MD